Comparing the Efficacy of Lyophilized Self Growth Factor Versus PRP Injection for Knee OA
Condition(s) studied
Investigational drug(s) / intervention(s)
Lyophilized self growth factor: Knee Intraarticular injection with Lyophilized self growth factor
Platelet-Rich Plasma(PRP): Knee Intraarticular injection with Lyophilized self growth factor
Placebo: Knee Intraarticular injection with normal saline
Study summary
Knee osteoarthritis(OA) is a common degenerative joint disease that often leads to knee pain, stiffness, and a decline in quality of life among middle-aged and elderly individuals. Platelet-rich plasma (PRP) is a regenerative treatment method that involves drawing a small amount of the patient's own blood and using centrifugation process to produce PRP. PRP, which is rich in growth factors and anti-inflammatory cytokines, facilitate the repair of damaged tissues and has been used in treating knee OA. Self-repair factor (SRF), an advanced form of PRP, is created using multi-step centrifugation and proprietary processes to increase platelet concentration. This enhancement may offer superior repair efficacy and faster recovery compared to traditional PRP. To explore this potential, we designed a randomized, double-blind, clinical trial to compare the effectiveness of SRF and PRP in treating degenerative knee osteoarthritis.
Eligibility
Primary outcome measure(s)
- Western Ontario and McMaster Universities Osteoarthritis Index — Pre-treatment, 1st month, 2nd month, 3rd month, 6th month
The structure and function of the knee joint are assessed from three main aspects: pain, stiffness, and joint function, with a total of 24 items. The pain section consists of 5 items (24 points in total), the stiffness section has 2 items (8 points in total), and the joint function section includes 17 items (68 points in total). A lower score indicates more severe pain, stiffness, and a higher degree of disability.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| No. 325, Sec. 2, Chenggong Rd., Neihu Dist. | Taipei | Taiwan | Recruiting |
More Tri-Service General Hospital (TSGH) trials in Taiwan
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06932614 on ClinicalTrials.gov ↗ ← All trials in Taiwan